These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 29893708)
1. Rapamycin Combi with TAE on the Growth, Metastasis, and Prognosis of Hepatocellular Carcinoma in Rat Models. Lei HW; Cai J; Li CM; Yang F; Shi WQ; Shi WQ; Wang LP; Feng YY Ann Hepatol; 2018 July - August ,; 17(4):645-654. PubMed ID: 29893708 [TBL] [Abstract][Full Text] [Related]
2. Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model. Ni JY; Xu LF; Wang WD; Huang QS; Sun HL; Chen YT J Cancer Res Clin Oncol; 2017 Feb; 143(2):199-207. PubMed ID: 27638772 [TBL] [Abstract][Full Text] [Related]
3. Increased metastatic potential of residual carcinoma after transarterial embolization in rat with McA-RH7777 hepatoma. Wang GZ; Fang ZT; Zhang W; Qu XD; Qian S; Liu R; Wang JH Oncol Rep; 2014 Jan; 31(1):95-102. PubMed ID: 24173823 [TBL] [Abstract][Full Text] [Related]
4. Correlation of hypoxia-inducible factor 1alpha with angiogenesis in liver tumors after transcatheter arterial embolization in an animal model. Liang B; Zheng CS; Feng GS; Wu HP; Wang Y; Zhao H; Qian J; Liang HM Cardiovasc Intervent Radiol; 2010 Aug; 33(4):806-12. PubMed ID: 19937023 [TBL] [Abstract][Full Text] [Related]
5. A Combination of UTMD-Mediated HIF-1 Liao Y; Luo H; He Z; Kuang Y; Chen P; Zhang X; Chen J; Wen Q; Xie Y; Ding S Biomed Res Int; 2019; 2019():1937460. PubMed ID: 30911540 [TBL] [Abstract][Full Text] [Related]
6. Antisense hypoxia-inducible factor-1alpha augments transcatheter arterial embolization in the treatment of hepatocellular carcinomas in rats. Sun X; Jiang H; Jiang X; Tan H; Meng Q; Sun B; Xu R; Krissansen GW Hum Gene Ther; 2009 Apr; 20(4):314-24. PubMed ID: 19327024 [TBL] [Abstract][Full Text] [Related]
7. Mechanistic target of rapamycin small interfering RNA and rapamycin synergistically inhibit tumour growth in a mouse xenograft model of human oesophageal carcinoma. Sun MM; Zhang MZ; Chen Y; Li SL; Zhang W; Ya GW; Chen KS J Int Med Res; 2012; 40(5):1636-43. PubMed ID: 23206445 [TBL] [Abstract][Full Text] [Related]
8. RNA interference of hypoxia-inducible factor-1 alpha improves the effects of transcatheter arterial embolization in rat liver tumors. Chen C; Wang J; Liu R; Qian S Tumour Biol; 2012 Aug; 33(4):1095-103. PubMed ID: 22407533 [TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization. Liao XF; Yi JL; Li XR; Deng W; Yang ZF; Tian G World J Gastroenterol; 2004 Jul; 10(13):1885-9. PubMed ID: 15222029 [TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro. Wang GZ; Zhang W; Fang ZT; Zhang W; Yang MJ; Yang GW; Li S; Zhu L; Wang LL; Zhang WS; Liu R; Qian S; Wang JH; Qu XD J Cancer Res Clin Oncol; 2014 Jul; 140(7):1125-36. PubMed ID: 24756364 [TBL] [Abstract][Full Text] [Related]
11. Rapamycin enhances cetuximab cytotoxicity by inhibiting mTOR-mediated drug resistance in mesenchymal hepatoma cells. Chen W; Hu QD; Xia XF; Liang C; Liu H; Zhang Q; Ma T; Liang F; Liang TB Cancer Biol Ther; 2014 Aug; 15(8):992-9. PubMed ID: 24800850 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of curcumin liposome after transcatheter arterial embolization in VX2 rabbits. Zhang X; Dai F; Chen J; Xie X; Xu H; Bai C; Qiao W; Shen W Cancer Biol Ther; 2019; 20(5):642-652. PubMed ID: 30621501 [TBL] [Abstract][Full Text] [Related]
13. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling. Liu NN; Zhao N; Cai N IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388 [TBL] [Abstract][Full Text] [Related]
14. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice]. Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316 [TBL] [Abstract][Full Text] [Related]
15. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway. Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938 [TBL] [Abstract][Full Text] [Related]
16. Epithelial to mesenchymal transition is associated with rapamycin resistance. Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619 [TBL] [Abstract][Full Text] [Related]
17. Antitumoral activity of rapamycin mediated through inhibition of HIF-1alpha and VEGF in hepatocellular carcinoma. Wang W; Jia WD; Xu GL; Wang ZH; Li JS; Ma JL; Ge YS; Xie SX; Yu JH Dig Dis Sci; 2009 Oct; 54(10):2128-36. PubMed ID: 19052864 [TBL] [Abstract][Full Text] [Related]
18. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells. Cheng KY; Hao M Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743 [TBL] [Abstract][Full Text] [Related]
19. Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allografts. Tong H; Li X; Zhang CL; Gao JH; Wen SL; Huang ZY; Wen FQ; Fu P; Tang CW J Dig Dis; 2013 Jan; 14(1):29-37. PubMed ID: 23134145 [TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model. Lang SA; Gaumann A; Koehl GE; Seidel U; Bataille F; Klein D; Ellis LM; Bolder U; Hofstaedter F; Schlitt HJ; Geissler EK; Stoeltzing O Int J Cancer; 2007 Apr; 120(8):1803-10. PubMed ID: 17230506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]